StonvexLoading…
StonvexStonvexStonvexCore line items from APH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $23.09B | $15.22B | $12.55B | $12.62B |
Operating Income | $5.87B | $3.16B | $2.56B | $2.59B |
Net Income | $4.27B | $2.42B | $1.93B | $1.90B |
EPS (Diluted) | $3.34 | $1.92 | $1.55 | $1.53 |
Total Assets | $36.24B | $21.44B | $16.53B | $15.33B |
Total Liabilities | $22.73B | $11.58B | $8.10B | $8.23B |
Cash & Equivalents | $11.13B | $3.32B | $1.48B | $1.37B |
Free Cash Flow OCF − CapEx | $4.38B | $2.15B | $2.16B | $1.79B |
Shares Outstanding | 1.23B | 1.21B | 1.20B | 594.80M |